Search research articles
Contact Us
Filters
Showing results (221-230 of 276) with videos related to
Page
of 28
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
April 12, 2020
Toward Patient-Centered Innovation: A Conceptual Framework for Patient-Reported Outcome Measures for Transformative Kidney Replacement Devices
Jennifer E Flythe, Tandrea S Hilliard, Kourtney Ikeler, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes
P H Reggio, S Basu-Dutt, J Barnett-Norris, et al.
ACS Chemical Neuroscience
|
April 6, 2016
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe
Robert B Laprairie, Abhijit R Kulkarni, Pushkar M Kulkarni, et al.
Journal of Medicinal Chemistry
|
July 8, 2005
Adamantyl cannabinoids: a novel class of cannabinergic ligands
Dai Lu, Zhaoxing Meng, Ganesh A Thakur, et al.
The American Journal of Tropical Medicine and Hygiene
|
October 28, 2015
Incidence of Pneumococcal Pneumonia Among Adults in Rural Thailand, 2006-2011: Implications for Pneumococcal Vaccine Considerations
Barameht Piralam, Sara M Tomczyk, Julia C Rhodes, et al.
Bioorganic & Medicinal Chemistry
|
July 5, 2017
Design, synthesis and biological evaluation of GPR55 agonists
Lara Fakhouri, Christopher D Cook, Mohammed H Al-Huniti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 16, 2015
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior
Miriam Schneider, Fernando Kasanetz, Diane L Lynch, et al.
Journal of Medicinal Chemistry
|
October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides
Valentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
Biochemistry
|
May 4, 2011
Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands
Evangelia Kotsikorou, Karla E Madrigal, Dow P Hurst, et al.
The Lancet. Microbe
|
November 16, 2024
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Xin Hui S Chan, Ilsa L Haeusler, Bennett J K Choy, et al.
Page
of 28
Search research articles
Search
Showing results (221-230 of 276) with videos related to
Sort By:
Page
of 28
Clinical Journal of the American Society of Nephrology : CJASN
|
April 12, 2020
Toward Patient-Centered Innovation: A Conceptual Framework for Patient-Reported Outcome Measures for Transformative Kidney Replacement Devices
Jennifer E Flythe, Tandrea S Hilliard, Kourtney Ikeler, et al.
Journal of Medicinal Chemistry
|
December 19, 1998
The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes
P H Reggio, S Basu-Dutt, J Barnett-Norris, et al.
ACS Chemical Neuroscience
|
April 6, 2016
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding Probe
Robert B Laprairie, Abhijit R Kulkarni, Pushkar M Kulkarni, et al.
Journal of Medicinal Chemistry
|
July 8, 2005
Adamantyl cannabinoids: a novel class of cannabinergic ligands
Dai Lu, Zhaoxing Meng, Ganesh A Thakur, et al.
The American Journal of Tropical Medicine and Hygiene
|
October 28, 2015
Incidence of Pneumococcal Pneumonia Among Adults in Rural Thailand, 2006-2011: Implications for Pneumococcal Vaccine Considerations
Barameht Piralam, Sara M Tomczyk, Julia C Rhodes, et al.
Bioorganic & Medicinal Chemistry
|
July 5, 2017
Design, synthesis and biological evaluation of GPR55 agonists
Lara Fakhouri, Christopher D Cook, Mohammed H Al-Huniti, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 16, 2015
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior
Miriam Schneider, Fernando Kasanetz, Diane L Lynch, et al.
Journal of Medicinal Chemistry
|
October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamides
Valentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
Biochemistry
|
May 4, 2011
Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands
Evangelia Kotsikorou, Karla E Madrigal, Dow P Hurst, et al.
The Lancet. Microbe
|
November 16, 2024
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Xin Hui S Chan, Ilsa L Haeusler, Bennett J K Choy, et al.
Page
of 28